Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

Current standard adjuvant therapy of glioblastoma multiforme (GBM) using temozolomide (TMZ) frequently fails due to therapy resistance. Thus, novel therapeutic approaches are highly demanded. We tested the therapeutic efficacy of the second-generation XPO1 inhibitor Eltanexor using assays for cell v...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Otte, Katharina, Zhao, Kai, Braun, Madita, Neubauer, Andreas, Raifer, Hartmann, Helmprobst, Frederik, Barrera, Felipe Ovalle, Nimsky, Christopher, Bartsch, Jörg W., Rusch, Tillmann
Formaat: Artikel
Taal:Engels
Gepubliceerd in: Philipps-Universität Marburg 2022
Onderwerpen:
radiosensitivity
XPO1
Eltanexor
SINE
temozolomide
Medizin
GBM
Medical sciences Medicine
Online toegang:PDF Full text
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
Publikationen im Open Access gefördert durch die UB

Gelijkaardige items